Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$15,960,015
-$2,078,388 QoQ
Shares Held
63,424
-23.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#713
of 4,153 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IBEX WEALTH ADVISORS holds $67,705,763 across 7 Drug Manufacturers - General names. ABBV ranks #1 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
63,424 | $15,960,015 | |
| 2 | LLY |
ELI LILLY & Co
|
12,208 | $14,642,642 | |
| 3 | MRK |
Merck & Co., Inc.
|
103,751 | $13,332,003 | |
| 4 | AMGN |
Amgen Inc
|
31,655 | $11,462,908 | |
| 5 | PFE |
Pfizer Inc
|
389,557 | $9,380,532 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
15,711 | $1,984,927 | |
| 7 | JNJ |
Johnson & Johnson
|
3,712 | $942,736 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,960,015 | 63,424 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $18,038,403 | 82,939 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $13,560,424 | 59,348 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,637,011 | 58,897 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,845,034 | 58,426 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $11,904,088 | 56,816 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $9,870,168 | 55,544 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $10,997,068 | 55,687 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $9,014,405 | 52,556 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $8,175 | 50,587 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $7,593 | 49 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $7,478,340 | 50,170 | Shares | Sole | 2023-11-07 | |
| 2023-03-31 | $8,761,525 | 54,976 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,175,365 | 50,587 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $8,581,118 | 63,938 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $7,741,625 | 50,546 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $8,062,540 | 49,735 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,100,311 | 45,054 | Shares | Sole | 2022-02-22 | |
| 2021-09-30 | $4,339,825 | 40,232 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,185,702 | 37,160 | Shares | Sole | 2021-08-20 | |
| 2020-09-30 | $2,655,641 | 30,319 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,848,201 | 29,010 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||